A research team has developed a causal deep learning model to personalize corticosteroid therapy for intensive care unit ...

The addition of steroids to standard care significantly reduces the risk for death in adults with community-acquired ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

Josh Lloyd, aged 23 and from Newcastle, developed cataracts in one eye as a result of steroid treatment for eczema ...

Following a lengthy R&D process, two new molecules from Biogen could add much-needed treatments for a disease that’s been difficult to pin down.

A few things happen when you get a corticosteroid injection at the dermatologist’s office. “We inject it into active inflamed ...

- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

Arcutis tapped the mother-daughter duo to discuss their experiences in the “Free to Be Me” campaign. The goal, according to the company, is to show the emotional and physical burden of inflammatory ...

Mean overall KOOS score at baseline was 43. Baseline PROMIS scores averaged about 44 for pain intensity, 53 for pain behavior ...

ClearPen promises a breakthrough in acne relief with easy, effective at-home steroid injections. Find out when this treatment ...

Chronic obstructive pulmonary disease is a condition caused by damage to the lungs that results in breathing difficulties.

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.